CD44 and hepatocellular carcinoma: Compared with adjacent non-tumor liver tissue, clinical studies have shown that HCC commonly exhibits peritumoral or stromal HA enrichment together with increased expression of HA receptors, particularly CD44 and RHAMM, features linked to invasion, immune suppression, and poorer outcomes (Figure 4) [13,93].